Development of Targeted Drugs for Osteoporosis

Grant

Date/time Interval

  • March 15, 2019 - February 28, 2022
  • Total Award Amount

  • 465138.00
  • Direct Costs

  • 382533.00
  • Sponsor Award Id

  • R21AR074569
  • Contributor

  • Xu Feng Ph.D.   Principal Investigator